13th International Cancer and Medical Oncology Conference & Exhibition

Name: 13th International Cancer and Medical Oncology Conference & Exhibition
Start: 2027-02-01T08:00
End: 2027-02-02T18:00
Location: Novotel Al Barsha

CancerUCG

2027-02-01 – 2027-02-02 · Novotel Al Barsha · DUBAI · UAE · Hybrid · 30 CME/CPD Credits by The ACCME CME

Advancing Cancer Research, Diagnostics, and Precision Oncology

Speakers

Dr. Abdulaziz Alomiery — Assistant Professor at the Basic Science Department, King Saud University
Dr. Advait Ajit Karmarkar — First Year Resident, Dept of Pathology, Dr DY Patil Medical College
Dr. Ahmed Yehia Sharab — Distinguished Physician, Co-Founder and CEO, HCMA AI
Dr. Aisha Memon — Assistant Professor and a Consultant Histopathologist, Aga Khan University Hospital, Karachi, Pakistan
Dr. Aishwarya Thakurdesai — MBBS from Seth G. S. Medical College in Mumbai, Garnered Several Awards and Honors, Including the 2024 AASLD Foundation Emerging Liver Scholar Award
Dr. Akanksha Anu — Advances in Thyroid Pathology
Dr. Akanksha Pandey — Department of Pathology, Heritage Institute of Medical Sciences, Varanasi
Dr. Aliyarbayova Aygun Aliyar — Assistant professor of Department of Cytology, embryology and Histology, Azerbaijan Medical University
Dr. Ashwini Malla — Assistant Professor, PSG College of Arts and Science
Dr. Babatope Lanre Awosusi — Head of the Histopathology Department, King Khalid General Hospital, Al Majmaah
Dr. Bangkang Fu — Research primarily focuses on cardiovascular, neurological, and oncological imaging, Guizhou University
Dr. Batool Ahmad — Pathology Resident, LN Medical College and J.K. Hospital
Dr. Emil Salmo — Consultant Pathologist, Department of Histopathology, The Royal Oldham Hopspita
Dr. Eshraq El Masry — DHA-licensed Clinical Oncologist and General Practitioner based in the UAE
Dr. Esraa Aldujaily — Head of the Department of Pathology and Forensic Medicine, University of Kufa/ Faculty of Medicine
Dr. Folinas Konstantinos — Consultant Medical Oncologist, Oncology Department of 251 Airforce General Hospital
Dr. Gurbanova Shahana Gazanfar — Assistant of Department of Cytology, Embryology and Histology, Azerbaijan Medical University
Dr. Hadassah Sade — Managing Director at AstraZeneca Computational Pathology, AstraZeneca
Dr. Iskander Chaudhry — Consultant Pathologist, Royal Blackburn Teaching Hospital
Dr. Jose Manuel Cervera-Grau — Medical Oncology (18ys) INCLIVA in Spain, International Cancer Care Society
Dr. Juliana Bicca — Speaker, Vice-President of the Brazilian Academy of Functional and Integrative Medicine
Dr. Khalid Al-Baimani — Medical Oncologist
Dr. Khan Ummiya Afreen — Department of Pathology, Kamineni Academy Of Medical Sciences And Research Center
Dr. Leon Wreyford — Oncologist Communication / Health Professional, University of Southern Queensland
Dr. Maria Putova — Biologist-Researcher in Clinical Laboratory Diagnostics, Moscow Clinical Scientific Center
Dr. Matus Coma — Leading scientist at the Department of Pharmacology, Medical Faculty, Pavol Jozef Safarik University
Dr Meg Rynderman OAM — Australian Cancer Survivorship Centre at Peter, Consumer Advocate - Australian Cancer Survivorship Centre at Peter MacCallum Cancer Centre
Dr. Mehrdad Mohammadi — Assistant Professor SUMS and chief executive officer, Smart Medical Centre
Dr. Nada Shamina — Chemical Pathologist in the UK
Dr. Nariman Nawar — Pathologyist, West Virginia University | WVU · Department of Pathology MD
Dr. Neha Kamble — President- Medicare Charitable Trust Foundation, Dr. D.Y. Patil Medical College
Dr Neha Patel — CONSULTANT RADIATION ONCOLOGIST, ADDITIONAL MEDICAL DIRECTOR
Dr. Noskova Karina — Head of the Laboratory, Moscow Clinical Scientific Center
Dr. Pradeep Kumar Kar — Kidwai Memorial Institute of Oncology, Fortis Cancer Institute and Farcast Biosciences
Dr. Samira Yagubova — Associate professor, Department of Pathology, Azerbaijan Medical University
Dr Sanya Arora — Oncology Fellow, The London Clinic,, Clinical research fellow, ULCH,
Dr. Shahla Masood — Professor and Chair, Department of Pathology and Laboratory Medicine, University of Florida College of Medicine – Jacksonville
Dr. Shraddha Krupa — Pathology Resident
Dr. Silky Rai — Department of Oncopathology, Mahamana Pandit Madan Mohan Malviya Cancer Centre
Dr. Sviatoslav Zinovev — Oncologist, Nizhny Novgorod Research Institute of Oncology
Dr. Syeda Ayesha Fatima — Assistant Professor, Department of Pharmacology, Sulaiman Al Rajhi University
Dr. Tadeja Skok — Breast Cancer, Imaging Characteristics in Breast Cancer
Dr. Voropaeva Yana — Physician of Clinical laboratory diagnostics, Moscow Clinical Scientific Center
Dr. Wardah Fatima — Oral Pathology resident at Ziauddin University, Karachi, Can Saliva Replace Tissue? The Role of Liquid Biopsy and AI in Oral Oncology
Dr. Weam Mohamed Ahmed Eltoum — Consultant Histopathologist, Stockport NHS Foundation Trust
Eléonore DJIKEUSSI — Founder, Oncologist–Hematologist & Nutrition Expert, NutriGnosis SA
Mr. Alexandre Mendes — Cardio-Oncology & Patient Safety
Mr. Omar Ali — Former NICE adviser and head of payers at Verpora
Mr. Salam Musa — Consultant Oncoplastic breast surgeon, Presentation Focus: Impact of Breast Surgery on Patients
Mrs. Uta Rouse Bsc — VE-comedus UG™, Hospizinitiative Rostock e.V.
Ms. Ginny Dent Brant — Cancer Survivor, Holistic Healing Approaches &amp;amp; Cancer Survivorship
Ms. Rania Mohamad Othman, Al-Sham Private University
Prof. Nadia Sam — Laboratory of language, University of Blida2 Lounici-Algeria

Tracks

Track 1-Cancer: Cancer: An Overview **[Cancer](https://cancer.ucgconferences.com/submit-abstract)** is a complex group of diseases characterized by the uncontrolled growth and proliferation of abnormal cells. These c
Track 2: Medical Oncology: Definition of **[Medical Oncology](https://cancer.ucgconferences.com/submit-abstract)** Medical Oncology is a specialized branch of medicine that focuses on the prevention, diagnosis, and treatment of
Track 3:Immunotherapy: **[Immunotherapy](https://cancer.ucgconferences.com/submit-abstract)** is a type of medical treatment that harnesses the body’s immune system to fight diseases, particularly cancer. Unlike conventiona
Track 4: Radiotherapy: **[Radiotherapy](https://cancer.ucgconferences.com/submit-abstract)** also known as radiation therapy, is a medical treatment that uses high-energy radiation to destroy cancer cells or control their g
Track 5: Chemotherapy: **[Chemotherapy](https://cancer.ucgconferences.com/submit-abstract)** is a type of cancer treatment that uses drugs to destroy or slow the growth of cancer cells. These drugs work by targeting rapidly
Track 6: Surgical Oncology: ** [Surgical oncology](https://cancer.ucgconferences.com/submit-abstract)** is a specialized branch of medicine focused on the surgical management of cancer. It involves the use of surgery to diagnose
Track 7: Hormone-therapy: A treatment that involves the use of **[hormones](https://cancer.ucgconferences.com/submit-abstract)** or hormone-blocking medications to manage conditions related to hormonal imbalances or deficienci
Track 8: Leukemia: **[Leukemia](https://cancer.ucgconferences.com/submit-abstract)** is a type of cancer that affects the blood and bone marrow, which is the soft, spongy tissue inside bones where blood cells are produc
Track9: Cancer Genetics: ** [Cancer genetics](https://cancer.ucgconferences.com/submit-abstract)** is the study of genetic mutations and alterations that drive the initiation, progression, and metastasis of cancer. It focuses
Track 10: Cancer Epigenetics: **[Cancer epigenetics](https://cancer.ucgconferences.com/submit-abstract)** refers to the study of heritable changes in gene expression that occur without alterations in the DNA sequence. These change
Track 11: Tumor Microenvironment: The tumor microenvironment (TME) refers to the complex and dynamic ecosystem surrounding a tumor, composed of various non-cancerous cells, molecules, and extracellular components that interact with ca
Track 12: Cancer Metastasis: Cancer metastasis refers to the process by which cancer cells spread from their original (primary) site to other parts of the body, forming new (secondary) tumors. This is a hallmark of cancer progres
Track 13: Breast cancer: Breast cancer is a type of cancer that begins in the cells of the breast tissue. It occurs when cells in the breast grow uncontrollably and form a tumor, which can be benign (non-cancerous) or maligna
Track 14: Lung Cancer: Lung cancer is a type of cancer that begins in the lungs, commonly caused by smoking, exposure to harmful substances, or genetic factors. It involves abnormal cell growth, forming tumors that can inte
Track 15: Colorectal Cancer: Colorectal cancer is a type of cancer that starts in the colon (large intestine) or the rectum, which are parts of the digestive system. It usually begins as small, noncancerous growths called polyps
Track 16: Prostate Cancer: Prostate cancer is a type of cancer that develops in the prostate gland, which is a small, walnut-shaped gland in males responsible for producing seminal fluid that nourishes and transports sperm. Thi
Track 17: Skin Cancer: Skin cancer is the uncontrolled growth of abnormal skin cells, often caused by ultraviolet (UV) radiation exposure, that can invade nearby tissues or spread to other parts of the body.
Track 18: Blood Cancer: Blood cancer, also known as hematologic cancer, is a group of cancers that affect the blood, bone marrow, and lymphatic system. These cancers interfere with the production and function of blood cells,
Track 19: Brain Tumor: Brain Tumor focuses on the study, diagnosis, treatment, and prevention of tumors that develop in the brain and central nervous system. This track covers advancements in neuro-oncology, neurosurgery, r
Track 20: Ovarian Cancer: Ovarian Cancer is a type of cancer that begins in the ovaries, which are part of the female reproductive system. The ovaries are responsible for producing eggs (ova) and the hormones estrogen and prog
Track 21: Head and Neck Cancer: Head and neck cancer refers to a group of cancers that develop in the tissues or organs of the head and neck region, including the mouth, throat, larynx (voice box), sinuses, salivary glands, and nasa
Track 22:Pancreatic Cancer: Pancreatic cancer is known for its poor prognosis because it is often diagnosed at an advanced stage. However, early detection and treatment can improve outcomes.
Track 23: Liver cancer: Liver cancer is a type of cancer that originates in the liver, a vital organ located in the upper right side of the abdomen. The liver is responsible for essential functions such as detoxifying the bl
Track 24: Bone Cancer: Bone cancer is a type of cancer that originates in the cells of the bone. It occurs when abnormal cells in the bone grow uncontrollably, forming a tumor. These tumors can be benign (non-cancerous) or
Track 25:Cancer Stem Cells: Cancer Stem Cells (CSCs) are a subpopulation of cancer cells within a tumor that possess characteristics similar to normal stem cells. They have the ability to self-renew and differentiate into variou
Track 26:Cancer Biomarkers: Cancer biomarkers are biological molecules found in blood, other body fluids, or tissues that indicate the presence, progression, or characteristics of cancer. These biomarkers can be produced directl
Track 27: Precision Oncology: Precision Oncology is a field of cancer treatment that tailors medical care to the individual characteristics of each patient and their cancer. It leverages advanced technologies, such as genomic sequ
Track 28: Cancer Prevention: Cancer Prevention refers to proactive measures taken to reduce the risk of developing cancer. It involves identifying and minimizing risk factors, promoting protective factors, and implementing strate
Track 29:Cancer Epidemiology: Cancer Epidemiology is the study of the distribution, determinants, and prevention of cancer in populations. It examines the patterns, causes, and risk factors associated with cancer development and p
Track 30:Cancer Screening: Cancer Screening refers to the process of identifying cancer or precancerous conditions in individuals who do not have any symptoms of the disease. The primary goal of cancer screening is to detect ca

Programme

Mon 1 Feb 2027 — 08:00–08:30 — Registration
Mon 1 Feb 2027 — 08:30–09:00 — Opening Ceremony
Mon 1 Feb 2027 — 09:00–10:00 — Keynote Introduction & Speech
Mon 1 Feb 2027 — 10:00–22:30 — Speech & Poster Presentation
Mon 1 Feb 2027 — 10:30–10:45 — Coffee Break and Networking
Mon 1 Feb 2027 — 10:45–11:30 — Exhibit Hall Open
Mon 1 Feb 2027 — 11:00–13:00 — Speaker & Poster Presentations
Mon 1 Feb 2027 — 13:00–13:10 — Professional Photography
Mon 1 Feb 2027 — 13:10–14:00 — Lunch Break & Networking
Mon 1 Feb 2027 — 14:00–16:00 — Speaker & Poster Presentations
Mon 1 Feb 2027 — 16:00–16:15 — Coffee Break & Networking
Mon 1 Feb 2027 — 16:15–17:00 — Speech & Poster Presentation
Mon 1 Feb 2027 — 17:00–17:30 — Panel Discussion
Mon 1 Feb 2027 — 17:30–18:00 — Closing Remarks
Mon 1 Feb 2027 — 17:30–17:45 — Certificate Distribution
Mon 1 Feb 2027 — 17:00–18:00 — Professional Photography

Registration

Abstract/Presentation/Poster Review Fee — USD 30
Abstract/Presentation/Poster Review Fee — USD 60
Speaker/Poster 1 Day Entry — USD 200
Speaker/Poster Package — USD 350
Speaker/Poster 1 Day Entry — USD 400
Speaker/Poster Package — USD 700
Delegate/Listener 1 Day Entry — USD 175
Delegate/Listener Package — USD 300
Group Pass(3 Attendees) — USD 750
30 CME/CPD Credits — USD 300
Certificate(Mandatory) — USD 50
Package A(30 CME Credits) — USD 899
Package B(30 CME Credits) — USD 1099
Student Fee (ID card required) — USD 150
Visa Invitation Letter — USD 75
Delegate/Listener 1 Day Entry — USD 350
Delegate/Listener Package — USD 600
Group Pass(3 Attendees) — USD 1500
30 CME/CPD Credits — USD 600
Certificate(Mandatory) — USD 136